All Resources

Community protection and opioid stewardship standards

Description

The Community Protection and Opioid Stewardship Standards, along with the Mental Health Services Protection Regulation and the Mental Health Services Protection Act, set the minimum requirements... More ≫

Description

The Community Protection and Opioid Stewardship Standards, along with the Mental Health Services Protection Regulation and the Mental Health Services Protection Act, set the minimum requirements that a licensed narcotic transition service provider must comply with in the provision of narcotic transition services.

Tags

Opioid agonist therapy. Gap Coverage Program : information for health care providers

Description

Opioid agonist therapy (OAT), which entails the provision of medications like oral buprenorphine/naloxone, methadone or injectable extended-release buprenorphine, is an evidence-based treatment... More ≫

Description

Opioid agonist therapy (OAT), which entails the provision of medications like oral buprenorphine/naloxone, methadone or injectable extended-release buprenorphine, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for health care providers about the OAT Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.

Tags

Opioid agonist therapy. Gap Coverage Program : information for patients

Description

Opioid agonist therapy (OAT), which entails the provision of medications like oral buprenorphine/naloxone, methadone or injectable extended-release buprenorphine, is an evidence-based treatment... More ≫

Description

Opioid agonist therapy (OAT), which entails the provision of medications like oral buprenorphine/naloxone, methadone or injectable extended-release buprenorphine, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for patients about Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.

Tags